Literature DB >> 25693813

Maximizing computational tools for successful drug discovery.

Chanin Nantasenamat1, Virapong Prachayasittikul.   

Abstract

Drug discovery is an iterative cycle of identifying promising hits followed by lead optimization via bioisosteric replacements. In the search for compounds affording good bioactivity, equal importance should also be placed on achieving those with favorable pharmacokinetic properties. Thus, the balance and realization of both key properties is an intricate problem that requires great caution. In this editorial, the authors explore the available computational tools in the context of the extant of big data that has borne out via advents of the Omics revolution. As such, the selection of appropriate computational tools for analyzing the vast number of chemical libraries, target proteins and interactomes is the first step toward maximizing the chance for success. However, in order to realize this, it is also necessary to have a solid foundation on the big concepts of drug discovery as well as knowing which tools are available in order to give drug discovery scientists the best opportunity.

Keywords:  bioinformatics; cheminformatics; chemogenomics; computational tools; data mining; drug discovery

Mesh:

Substances:

Year:  2015        PMID: 25693813     DOI: 10.1517/17460441.2015.1016497

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  19 in total

Review 1.  Modern approaches to accelerate discovery of new antischistosomal drugs.

Authors:  Bruno Junior Neves; Eugene Muratov; Renato Beilner Machado; Carolina Horta Andrade; Pedro Vitor Lemos Cravo
Journal:  Expert Opin Drug Discov       Date:  2016-05-03       Impact factor: 6.098

2.  Production and characterization of antibody against Opisthorchis viverrini via phage display and molecular simulation.

Authors:  Sitthinon Siripanthong; Anchalee Techasen; Chanin Nantasenamat; Aijaz Ahmad Malik; Paiboon Sithithaworn; Chanvit Leelayuwat; Amonrat Jumnainsong
Journal:  PLoS One       Date:  2021-03-23       Impact factor: 3.240

Review 3.  Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.

Authors:  Benjamin Wooden; Nicolas Goossens; Yujin Hoshida; Scott L Friedman
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 33.883

4.  Classification of P-glycoprotein-interacting compounds using machine learning methods.

Authors:  Veda Prachayasittikul; Apilak Worachartcheewan; Watshara Shoombuatong; Virapong Prachayasittikul; Chanin Nantasenamat
Journal:  EXCLI J       Date:  2015-08-19       Impact factor: 4.068

5.  osFP: a web server for predicting the oligomeric states of fluorescent proteins.

Authors:  Saw Simeon; Watshara Shoombuatong; Nuttapat Anuwongcharoen; Likit Preeyanon; Virapong Prachayasittikul; Jarl E S Wikberg; Chanin Nantasenamat
Journal:  J Cheminform       Date:  2016-12-20       Impact factor: 5.514

Review 6.  Quantum mechanics implementation in drug-design workflows: does it really help?

Authors:  Olayide A Arodola; Mahmoud Es Soliman
Journal:  Drug Des Devel Ther       Date:  2017-08-31       Impact factor: 4.162

Review 7.  Unraveling the bioactivity of anticancer peptides as deduced from machine learning.

Authors:  Watshara Shoombuatong; Nalini Schaduangrat; Chanin Nantasenamat
Journal:  EXCLI J       Date:  2018-07-25       Impact factor: 4.068

Review 8.  Towards understanding aromatase inhibitory activity via QSAR modeling.

Authors:  Watshara Shoombuatong; Nalini Schaduangrat; Chanin Nantasenamat
Journal:  EXCLI J       Date:  2018-07-20       Impact factor: 4.068

9.  New Mammalian Target of Rapamycin (mTOR) Modulators Derived from Natural Product Databases and Marine Extracts by Using Molecular Docking Techniques.

Authors:  Verónica Ruiz-Torres; Maria Losada-Echeberría; Maria Herranz-López; Enrique Barrajón-Catalán; Vicente Galiano; Vicente Micol; José Antonio Encinar
Journal:  Mar Drugs       Date:  2018-10-15       Impact factor: 5.118

Review 10.  Data mining for the identification of metabolic syndrome status.

Authors:  Apilak Worachartcheewan; Nalini Schaduangrat; Virapong Prachayasittikul; Chanin Nantasenamat
Journal:  EXCLI J       Date:  2018-01-10       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.